We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AYTU market cap is 10.33M. The company's latest EPS is USD -2.5765 and P/E is -0.65.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.1M | 22.93M | 17.99M | 17.98M | 16.57M |
| Operating Income | -1.5M | 2.36M | -2.46M | -3.65M | -930k |
| Net Income | -8.12M | -220k | -2.89M | -4.62M | 1.09M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 27.63M | 65.63M | 96.67M | 107.4M | 81M |
| Operating Income | -21.13M | -58.87M | -111.56M | -12.33M | -5.25M |
| Net Income | -13.62M | -58.29M | -110.17M | -17.05M | -15.84M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 132.89M | 131.25M | 128.86M | 118.1M | 0 |
| Total Liabilities | 100.72M | 98.4M | 98.09M | 90.38M | 0 |
| Total Equity | 32.17M | 32.85M | 30.78M | 27.72M | 0 |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 152.84M | 265.67M | 137.62M | 136.46M | 118.1M |
| Total Liabilities | 57.82M | 128.1M | 91.53M | 97.11M | 90.38M |
| Total Equity | 95.02M | 137.57M | 46.09M | 39.36M | 27.72M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -211k | -346k | -600k | -1.39M | N/A |
| Investing | -76k | -250k | -295k | -329k | N/A |
| Financing | -2.73M | -2.86M | -2.33M | -1.26M | N/A |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -28.37M | -25.96M | -28.82M | -5.13M | -1.39M |
| Investing | -5.66M | -2.78M | -3.25M | -117k | -329k |
| Financing | 71.07M | 30.31M | 1.53M | 8.87M | -1.26M |
| Market Cap | 10.33M |
| Price to Earnings Ratio | -0.65 |
| Price to Sales Ratio | 0.13 |
| Price to Cash Ratio | 0.52 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 6.15M |
| Average Volume (1 week) | 13.54k |
| Average Volume (1 Month) | 22.91k |
| 52 Week Change | -41.05% |
| 52 Week High | 3.45 |
| 52 Week Low | 1.3001 |
| Spread (Intraday) | 0.24 (13.04%) |
| Company Name | AYTU BioPharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aytubio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
